USU Software AG resolves public share buyback offer
The offer price of EUR 18,75 is equivalent to a premium of around 10% based on the arithmetic average of the price of the company’s shares in the closing auction in Xetra trading on the Frankfurt stock exchange over the last ten trading days before the publication of this decision to make a public tender offer.
USU Software AG is thus exercising the authorization to acquire its own shares that was resolved by the company’s Annual General Meeting on June 26, 2020. The repurchased shares can be used for the purposes stipulated in the authorization resolution.
The offer period is due to begin on September 7, 2022 at 00:00 a.m. (CET) and end at midnight/12:00 p.m. (CET) on October 5, 2022. The offer document will be published in the Federal Gazette on September 7, 2022, from which date it will also be available on the company’s website.
Description to this ad hoc announcement:
USU increased its consolidated sales by approximately 15% to EUR 30.7 million and its EBITDA by more than 9% to EUR 3.8 million (Q2/2021: EUR 3.5 million) in the second quarter of 2022 alone. Over the first half of the year, USU’s consolidated sales rose by approximately 12% to EUR 60.3 million (Q1-Q2/2021: EUR 53.9 million) while its EBITDA grew by more than 9% to EUR 7.3 million (Q1-Q2/2021: EUR 6.7 million). The USU Group’s liquidity also increased to EUR 26.3 million as of June 30, 2022 (December 31, 2021: EUR 24.3 million). Furthermore, thanks to a large number of new and follow-up orders, USU set a new record for orders on hand of EUR 78.3 million as of the end of the second quarter of 2022 (June 30, 2021: EUR 66.2 million).
USU Software AG
Spitalhof
71696 Möglingen
Telefon: +49 (7141) 4867-0
Telefax: +49 (7141) 4867-200
http://www.usu.com
Investor Relations
Telefon: +49 (7141) 4867-351
Fax: +49 (7141) 4867-108
E-Mail: falk.sorge@usu.com
Corporate Communications
Telefon: +49 (7141) 4867-440
Fax: +49 (7141) 4867-300
E-Mail: thomas.gerick@usu.com
phronesis PR GmbH
Telefon: +49 (821) 444800
Fax: +49 (821) 4448022
E-Mail: moerz@phronesis.de